Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.22M Sell
22,691
-170
-0.7% -$58.2K 0.86% 34
2026
Q1
$8.04M Buy
22,861
+292
+1% +$104K 0.92% 30
2025
Q4
$7.39M Sell
22,569
-213
-0.9% -$67.6K 0.82% 35
2025
Q3
$6.43M Buy
22,782
+36
+0.2% +$10.4K 0.73% 38
2025
Q2
$6.35M Buy
22,746
+216
+1% +$61.2K 0.77% 37
2025
Q1
$7.02M Buy
22,530
+181
+0.8% +$53.4K 0.91% 30
2024
Q4
$5.83M Buy
22,349
+117
+0.5% +$34.7K 0.74% 39
2024
Q3
$7.16M Sell
22,232
-216
-1% -$70.7K 0.93% 31
2024
Q2
$7.01M Buy
22,448
+14
+0.1% +$4.11K 0.95% 29
2024
Q1
$6.38M Sell
22,434
-84
-0.4% -$24.6K 0.89% 37
2023
Q4
$6.49M Sell
22,518
-137
-0.6% -$37.3K 0.96% 31
2023
Q3
$6.09M Sell
22,655
-168
-0.7% -$41.9K 0.99% 29
2023
Q2
$5.07M Sell
22,823
-741
-3% -$172K 0.81% 36
2023
Q1
$5.7M Buy
23,564
+7
+0% +$1.72K 0.97% 31
2022
Q4
$6.19M Sell
23,557
-768
-3% -$206K 1.13% 30
2022
Q3
$5.48M Buy
24,325
+127
+0.5% +$30.8K 1.08% 28
2022
Q2
$5.89M Sell
24,198
-79
-0.3% -$19.4K 1.11% 26
2022
Q1
$5.87M Sell
24,277
-419
-2% -$96.3K 0.93% 31
2021
Q4
$5.56M Sell
24,696
-741
-3% -$156K 0.8% 37
2021
Q3
$5.41M Buy
25,437
+562
+2% +$129K 0.85% 38
2021
Q2
$6.06M Sell
24,875
-203
-0.8% -$49.9K 0.95% 32
2021
Q1
$6.24M Buy
25,078
+885
+4% +$211K 1.05% 30
2020
Q4
$5.56M Buy
24,193
+510
+2% +$118K 0.99% 29
2020
Q3
$6.02M Buy
23,683
+1,188
+5% +$294K 1.21% 22
2020
Q2
$5.31M Buy
22,495
+619
+3% +$141K 1.17% 26
2020
Q1
$4.43M Sell
21,876
-227
-1% -$49.6K 1.2% 26
2019
Q4
$5.33M Buy
22,103
+326
+1% +$71.9K 1.13% 26
2019
Q3
$4.21M Buy
21,777
+360
+2% +$69.1K 0.97% 30
2019
Q2
$3.95M Buy
21,417
+131
+0.6% +$23.5K 0.91% 33
2019
Q1
$4.04M Buy
21,286
+1,739
+9% +$332K 0.99% 29
2018
Q4
$3.81M Sell
19,547
-583
-3% -$114K 1.07% 29
2018
Q3
$4.17M Buy
20,130
+61
+0.3% +$12K 0.98% 31
2018
Q2
$3.71M Sell
20,069
-139
-0.7% -$24.6K 0.94% 35
2018
Q1
$3.44M Buy
20,208
+290
+1% +$53.2K 0.88% 39
2017
Q4
$3.46M Buy
19,918
+558
+3% +$98.8K 0.88% 40
2017
Q3
$3.61M Buy
19,360
+1,797
+10% +$318K 0.96% 35
2017
Q2
$3.02M Buy
17,563
+3,217
+22% +$523K 0.82% 43
2017
Q1
$2.35M Buy
14,346
+2,779
+24% +$462K 0.65% 51
2016
Q4
$1.69M Buy
11,567
+1,589
+16% +$239K 0.5% 63
2016
Q3
$1.66M Buy
9,978
+4,708
+89% +$796K 0.51% 62
2016
Q2
$802K Buy
5,270
+1,111
+27% +$173K 0.24% 93
2016
Q1
$624K Hold
4,159
0.2% 97
2015
Q4
$675K Sell
4,159
-28
-0.7% -$4.4K 0.21% 95
2015
Q3
$579K Buy
4,187
+25
+0.6% +$3.94K 0.2% 92
2015
Q2
$639K Buy
4,162
+3
+0.1% +$481 0.21% 93
2015
Q1
$665K Buy
4,159
+7
+0.2% +$1.1K 0.22% 92
2014
Q4
$661K Hold
4,152
0.22% 92
2014
Q3
$583K Hold
4,152
0.2% 93
2014
Q2
$491K Buy
4,152
+33
+0.8% +$3.82K 0.16% 109
2014
Q1
$508K Hold
4,119
0.18% 100
2013
Q4
$470K Buy
4,119
+10
+0.2% +$1.14K 0.16% 106
2013
Q3
$460K Buy
4,109
+250
+6% +$27.1K 0.18% 103
2013
Q2
$381K Buy
+3,859
New +$400K 0.16% 109

Other funds holding AMGN

J.W. Burns & Co's AMGN Position: Q2 2026 in Review

J.W. Burns & Co reduced its Amgen (AMGN) stake by 0.74% in Q2 2026, selling an estimated $58.2K and leaving 22,691 shares worth $8.22M. The position accounts for 0.86% of the portfolio, ranked #34.

J.W. Burns & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 1,244 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • J.W. Burns & Co held 22,691 shares of Amgen worth $8.22M as of Q2 2026.
  • J.W. Burns & Co sold 170 Amgen shares in Q2 2026, an estimated $58.2K.
  • Amgen made up 0.86% of J.W. Burns & Co's portfolio in Q2 2026, its #34 holding.
  • J.W. Burns & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 1,244 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on J.W. Burns & Co's 13F filing for Q2 2026, filed 15 Jul 2026.